Article Text

Download PDFPDF
Emergence of an imaging biomarker for amyotrophic lateral sclerosis: is the end point near?
  1. Michael Hornberger1,
  2. Matthew C Kiernan2
  1. 1Norwich Medical School, University of East Anglia, Norwich, UK
  2. 2Brain and Mind Centre and Sydney Medical School, University of Sydney, Sydney, Australia
  1. Correspondence to Professor Michael Hornberger, Norwich Medical School, University of East Anglia, Norwich NR4 7UQ, UK; m.hornberger{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

A diagnostic and treatment biomarker for amyotrophic lateral sclerosis (ALS) remains a holy grail.1 ,2 From a neuroimaging perspective, diffusion tensor imaging (DTI) has been increasingly utilised to identify brain-related upper motor neuron changes in ALS. In particular, the corticospinal tract, anterior corpus callosum and hippocampal fractional anisotropy (FA) white matter changes have been closely linked with ALS pathology3 ,4 and associated with the underlying neuropathological spread of TAR DNA binding protein 43 (TDP-43).5 Thus, DTI emerges as an ideal neuroimaging biomarker end point for disease-modifying trials in ALS. However, most advanced trials are run on a multicentre basis, and currently it is not clear how DTI signatures across centres in ALS hold-up, in particular with varying imaging sequences and scanner variabilities.

The study by Müller and colleagues6 addresses this point directly, by conducting a multicentre …

View Full Text


  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles

  • Neurodegeneration
    Hans-Peter Müller Martin R Turner Julian Grosskreutz Sharon Abrahams Peter Bede Varan Govind Johannes Prudlo Albert C Ludolph Massimo Filippi Jan Kassubek for The Neuroimaging Society in ALS (NiSALS) DTI Study Group Susanne Abdulla Federica Agosta Senda Ajroud-Driss Nazem Atassi Mark Bastin Michael Benatar William Brooks Andrea Calvo Arturo Cardenas-Blanco Adriano Chio Mamede De Carvalho Robert Dahnke Christian Enzinger Pilar Maria Ferraro Mary Kay Floeter Bradley Foerster Christian Gaser Ana Filipa Geraldo Martin Gorges Torsten Grehl Georg Groen Orla Hardiman Viktor Hartung Laura Jelsone-Swain Tom Jenkins Sanjay Kalra Elisabeth Kasper Hagen Kitzler Blaz Koritnik Magdalena Kuzma–Kozakiewicz Karl LaFleur Dorothée Lulé Judith Machts Avner Meoded Lewis Pettit MacDonald Euan Erik Pioro Barbara Poletti Pierre-Francois Pradat Tino Prell Malcolm Proudfoot Elena Ratti Nilo Riva Wim Robberecht Stefan Ropele Francois Salachas Ruben Schmidt Schmidt-Wilcke Christina Schuster Pamela Shaw Alex Sherman Vincenzo Silani Edoardo Gioele Spinelli Stefan Teipel Philip Van Damme Leonard Van den Berg Martin Van den Heuvel Esther Verstraete Renée Walhout Robert Welsh Markus Weber Henk-Jan Westeneng Matthias Wittstock Yana Yunusova